(07/05/2023)vs HEALTHCARE | 38 | 31 | 10 / 1283.3% | 3 / 933.3% | 5 / 862.5% | 8 / 1747.1% | | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 22 |
(30/04/2023)vs HEALTHCARE | 32 | 17 | 1 / 250% | 2 / 450% | 4 / 850% | 6 / 1250% | | 0 | 7 | 0 | 7 | 5 | 0 | 0 | 2 | 20 |
(26/03/2023)vs SALFO | 00 | 6 | 0 / 00% | 0 / 20% | 2 / 633.3% | 2 / 825% | | 4 | 6 | 0 | 6 | 2 | 2 | 0 | 1 | 9 |
(19/03/2023)vs ΔΗΜΟΣ ΚΗΦΙΣΙΑΣ | 37 | 17 | 4 / 944.4% | 5 / 771.4% | 1 / 812.5% | 6 / 1540% | | 1 | 2 | 1 | 3 | 2 | 2 | 0 | 0 | 10 |
(12/03/2023)vs ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 29 | 8 | 0 / 00% | 1 / 1100% | 2 / 728.6% | 3 / 837.5% | | 1 | 8 | 4 | 12 | 6 | 0 | 0 | 0 | 21 |
(19/02/2023)vs ΑΜΥΝΤΑΣ BC | 40 | 9 | 1 / 250% | 1 / 1100% | 2 / 922.2% | 3 / 1030% | | 2 | 7 | 0 | 7 | 3 | 1 | 0 | 2 | 10 |
(12/02/2023)vs ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 40 | 13 | 3 / 475% | 2 / 366.7% | 2 / 825% | 4 / 1136.4% | | 1 | 3 | 0 | 3 | 4 | 3 | 0 | 1 | 14 |
(29/01/2023)vs ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 28 | 18 | 2 / 450% | 2 / 2100% | 4 / 850% | 6 / 1060% | | 1 | 7 | 1 | 8 | 3 | 0 | 0 | 1 | 22 |
(22/01/2023)vs ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 36 | 6 | 1 / 250% | 1 / 520% | 1 / 333.3% | 2 / 825% | | 2 | 6 | 1 | 7 | 4 | 1 | 0 | 0 | 11 |
(15/01/2023)vs NEW MED | 00 | 23 | 8 / 8100% | 0 / 50% | 5 / 862.5% | 5 / 1338.5% | | 3 | 3 | 0 | 3 | 2 | 0 | 0 | 1 | 19 |
(03/12/2022)vs HEALTHCARE | 37 | 19 | 3 / 475% | 2 / 633.3% | 4 / 944.4% | 6 / 1540% | | 1 | 3 | 0 | 3 | 3 | 1 | 0 | 1 | 15 |
(27/11/2022)vs Σ.Ε.ΕΑΒ | 38 | 12 | 5 / 862.5% | 2 / 366.7% | 1 / 1010% | 3 / 1323.1% | | 5 | 6 | 0 | 6 | 4 | 2 | 0 | 1 | 10 |
(20/11/2022)vs ΔΗΜΟΣ ΚΗΦΙΣΙΑΣ | 31 | 15 | 4 / 4100% | 1 / 425% | 3 / 742.9% | 4 / 1136.4% | | 1 | 8 | 0 | 8 | 1 | 0 | 0 | 0 | 17 |
(13/11/2022)vs ΑΜΥΝΤΑΣ BC | 40 | 9 | 0 / 00% | 0 / 20% | 3 / 933.3% | 3 / 1127.3% | | 2 | 5 | 0 | 5 | 2 | 3 | 0 | 3 | 8 |
(23/10/2022)vs ΑΡΚΑΔΕΣ ΠΕΡΙΣΤΕΡΙΟΥ | 37 | 15 | 0 / 30% | 0 / 20% | 5 / 1145.5% | 5 / 1338.5% | | 3 | 7 | 1 | 8 | 3 | 2 | 0 | 2 | 15 |
(15/10/2022)vs SALFO | 37 | 14 | 6 / 785.7% | 1 / 425% | 2 / 633.3% | 3 / 1030% | | 0 | 6 | 0 | 6 | 3 | 2 | 0 | 0 | 17 |
(02/10/2022)vs ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 17 | 2 / 540% | 3 / 650% | 3 / 933.3% | 6 / 1540% | | 2 | 8 | 0 | 8 | 4 | 2 | 0 | 0 | 19 |
ΣΥΝΟΛΙΚΑ |
500 |
249 |
50 / 7467.6% |
26 / 6639.4% |
49 / 13436.6% |
75 / 20037.5% |
|
29 |
93 |
8 |
101 |
52 |
22 |
0 |
16 |
259 |
ΜΕΣΟΙ ΟΡΟΙ |
29.4 |
14.6 |
2.9 / 4.467.6% |
1.5 / 3.939.4% |
2.9 / 7.936.6% |
4.4 / 11.837.5% |
|
1.7 |
5.5 |
0.5 |
5.9 |
3.1 |
1.3 |
0 |
0.9 |
15.2 |